The results showed that EREG-induced PDL1 was significantly suppressed in presence of EGFR inhibitors, suggesting that activated EGFR is essential for PDL1 induction in HNSCC cells (Fig. 2d). The gene discussed is EGFR; the disease is head and neck squamous cell carcinoma.